These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 32902886)
1. Voice-Related Quality of Life in Idiopathic Subglottic Stenosis: Effect of Serial Intralesional Steroid Injections. Naunheim MR; Puka E; Choksawad K; Franco RA Laryngoscope; 2021 Feb; 131(2):366-369. PubMed ID: 32902886 [TBL] [Abstract][Full Text] [Related]
2. Awake serial intralesional steroid injections without surgery as a novel targeted treatment for idiopathic subglottic stenosis. Franco RA; Husain I; Reder L; Paddle P Laryngoscope; 2018 Mar; 128(3):610-617. PubMed ID: 28988454 [TBL] [Abstract][Full Text] [Related]
3. Voice-Related Quality of Life Is Associated with Postoperative Change in Subglottic Stenosis. Schuman AD; Neevel A; Morrison RJ; Hogikyan ND; Kupfer RA Laryngoscope; 2021 Feb; 131(2):360-365. PubMed ID: 33026661 [TBL] [Abstract][Full Text] [Related]
4. Impact of Serial Intralesional Steroid Injections on Idiopathic Subglottic Stenosis. Hoffman MR; Patro A; Huang LC; Chen SC; Berry LD; Gelbard A; Francis DO; Laryngoscope; 2023 Sep; 133(9):2255-2263. PubMed ID: 36286239 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-up of 64 Patients With Idiopathic Subglottic Stenosis: Treatment Pathways, Outcomes, and Impact of Serial Intralesional Steroid Injections. Schoeff S; Hoffman MR; Zhang Y; Yang Q; Dailey SH Ann Otol Rhinol Laryngol; 2023 Nov; 132(11):1341-1348. PubMed ID: 36840325 [TBL] [Abstract][Full Text] [Related]
6. Assessment of side effects after serial intralesional steroid injections for idiopathic subglottic stenosis. Celebi OO; Song SA; Santeerapharp A; Choksawad K; Franco RA Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):445-450. PubMed ID: 32948895 [TBL] [Abstract][Full Text] [Related]
7. Hyoid Bone Syndrome and Dysphonia: Can Throat Pain Affect the Voice? Rubin AD; Codino J; Bottalico P; Parrish S; Jackson-Menaldi C Laryngoscope; 2021 Jul; 131(7):E2303-E2308. PubMed ID: 33620110 [TBL] [Abstract][Full Text] [Related]
8. Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception. Braden MN; Johns MM; Klein AM; Delgaudio JM; Gilman M; Hapner ER J Voice; 2010 Mar; 24(2):242-9. PubMed ID: 19481417 [TBL] [Abstract][Full Text] [Related]
9. Voice quality in laryngotracheal stenosis: impact of dilation and level of stenosis. Hillel AT; Karatayli-Ozgursoy S; Benke JR; Best S; Pacheco-Lopez P; Teets K; Starmer H; Akst LM Ann Otol Rhinol Laryngol; 2015 May; 124(5):413-8. PubMed ID: 25519815 [TBL] [Abstract][Full Text] [Related]
10. Down-Regulation of a Profibrotic Transforming Growth Factor-β1/Cellular Communication Network Factor 2/Matrix Metalloprotease 9 Axis by Triamcinolone Improves Idiopathic Subglottic Stenosis. Treviño-Villarreal JH; Reynolds JS; Langston PK; Thompson A; Mitchell JR; Franco RA Am J Pathol; 2021 Aug; 191(8):1412-1430. PubMed ID: 34111429 [TBL] [Abstract][Full Text] [Related]
11. Correlation of the Voice Handicap Index-10 (VHI-10) and Voice-Related Quality of Life (V-RQOL) in patients with dysphonia. Romak JJ; Orbelo DM; Maragos NE; Ekbom DC J Voice; 2014 Mar; 28(2):237-40. PubMed ID: 24321582 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia. Morzaria S; Damrose EJ J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552 [TBL] [Abstract][Full Text] [Related]
13. The Subglottic Stenosis 6 Questionnaire: A Novel Quality-of-Life Survey Validated to Predict Need for Intervention in Patients With Idiopathic Subglottic Stenosis. Lu RJ; Hijaz B; Naunheim MR; Stevenson L; Franco RA Chest; 2024 Jan; 165(1):161-171. PubMed ID: 37544425 [TBL] [Abstract][Full Text] [Related]
14. Office-Based Steroid Injections for Idiopathic Subglottic Stenosis: Patient-Reported Outcomes, Effect on Stenosis, and Side Effects. Hoffman MR; Francis DO; Mai JP; Dailey SH Ann Otol Rhinol Laryngol; 2020 Apr; 129(4):361-368. PubMed ID: 31747777 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II. Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423 [TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Steroids for Prolonging the Surgery-Free Interval in Subglottic Stenosis. Langlie JA; Pasick LJ; Rosow DE Laryngoscope; 2023 Dec; 133(12):3436-3442. PubMed ID: 37278490 [TBL] [Abstract][Full Text] [Related]
17. Systemic safety of serial intralesional steroid injection for subglottic stenosis. Woliansky J; Phyland D; Paddle P Laryngoscope; 2019 Jul; 129(7):1634-1639. PubMed ID: 30582619 [TBL] [Abstract][Full Text] [Related]
18. Voice-related quality of life: Relation to objective spirometry measures in subglottic stenosis. Eggerstedt M; Kim YJ; Ritz EM; Patel TR; Theis SM; Husain IA Am J Otolaryngol; 2021; 42(5):103013. PubMed ID: 33838356 [TBL] [Abstract][Full Text] [Related]
19. Development of Cushing Syndrome After Serial In-office Subglottic Steroid Injections. Silverstein E; Bensoussan Y; O'Dell K Laryngoscope; 2022 May; 132(5):942-943. PubMed ID: 34002875 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal variations of laryngeal overpressure and voice-related quality of life in spasmodic dysphonia. Yeung JC; Fung K; Davis E; Rai SK; Day AM; Dzioba A; Bornbaum C; Doyle PC Laryngoscope; 2015 Mar; 125(3):661-6. PubMed ID: 25290557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]